We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ANZ:ASXANZ Group Holdings Limited Analysis

Data as of 2026-07-17 - not real-time

A$36.06

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ANZ shares have outperformed peer banks in the most recent fiscal year, reinforcing market confidence. Technical analysis shows the price sitting just above its short‑term moving average while still below the longer‑term average, indicating a modest upward bias. Momentum indicators are in positive territory, with the MACD histogram supporting a bullish tilt. The RSI sits in the middle range, suggesting there is still room for upside without immediate overbought concerns. Volatility is moderate, and the beta is low, underscoring the stock’s defensive character within the financial sector. The market sentiment index reflects extreme optimism, aligning with the strong earnings narrative.
Fundamentals reveal a price‑to‑earnings level slightly above the sector mean, yet the forward earnings multiple is comfortably lower, pointing to a potential valuation correction. A dividend yield near five percent combined with a high payout ratio offers attractive income but raises questions about cash‑flow sustainability. Operating cash flow is currently negative, which tempers confidence in the dividend’s long‑term durability. Analyst consensus is bullish, with a majority recommending a purchase and setting target prices near the current level. Recent commentary from reputable sources highlights three key reasons to consider the stock a compelling buy, emphasizing earnings forecasts and dividend appeal. Given the blend of defensive metrics, income potential, and positive earnings outlook, the stock is positioned for steady performance with limited downside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term support with neutral trend
  • positive momentum from MACD
  • high dividend yield offering immediate income

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • analyst consensus and target price alignment
  • forward earnings multiple indicating upside
  • income appeal from strong dividend

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • defensive low‑beta profile
  • uncertain cash‑flow sustainability for dividend
  • stable market position in diversified banking

Key Metrics & Analysis

Financial Health

Revenue Growth-2.10%
Profit Margin27.42%
P/E Ratio18.3
ROE8.24%
ROA0.45%
P/B Ratio1.5
Op. Cash FlowA$-17625999360
Industry P/E18.0

Technical Analysis

TrendNeutral
RSI56.3
SupportA$34.00
ResistanceA$36.60
MA 20A$35.53
MA 50A$35.20
MA 200A$36.38
MACDBullish
VolumeDecreasing
Fear & Greed Index89.16

Valuation

Target PriceA$35.48
Upside/Downside-1.62%
GradeFair
TypeValue
Dividend Yield4.60%

Risk Assessment

Beta0.38
Volatility17.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.